The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.975
Bid: 0.95
Ask: 1.00
Change: -0.025 (-2.50%)
Spread: 0.05 (5.263%)
Open: 1.00
High: 1.00
Low: 0.975
Prev. Close: 1.00
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Global collaboration agreement with Axcend Corp

26 Feb 2020 07:00

RNS Number : 1206E
Microsaic Systems plc
26 February 2020
 

26 Feb 2020

Microsaic Systems plc

 

("Microsaic" or the "Company")

 

Global collaboration and commercialisation agreement with Axcend Corp

 

Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments, is pleased to announce that it has signed a global integration and joint sales and marketing heads of terms with Axcend Corp ("Axcend") to integrate the compact Microsaic 4500 MiD® MS with the portable Axcend Focus LC® ("LC/MS system"), and to commercialise the combined system globally using both companies' direct sales and selected distribution channels. Microsaic has a direct sales presence in the UK and certain European markets, while Axcend has a direct presence in North America; both partners have extensive and growing networks of international distribution partners.

 

The Microsaic 4500 MiD® is a robust and compact MS detector with an integrated computer and vacuum pump, whose small footprint and ease of use make it deployable anywhere within a laboratory or processing facility. The Axcend Focus LC® is a very small footprint, high-performance liquid chromatography system ("HPLC").

 

Both LC and MS are standard analyses that are widely adopted and the ability to offer both in an easy-to-use compact LC/MS system is expected to deliver users with significant efficiency benefits without compromising on performance, speed or reliability.

 

Liquid chromatography ("LC") is a well-established method of sample separation. LC very commonly uses MS as a detection method in a wide range of markets, such as chemicals, pharmaceuticals and environmental analysis. Typically, due in part to the size and complexity of traditional LC and MS systems, such analyses are performed in a centralised laboratory. The combination of Axcend and Microsaic's small footprint technologies supports timely testing in the location where samples are taken, as well as in centralised laboratories. In addition, the combined LC/MS system utilises substantially less solvents than the traditonal LC and MS systems, which can, therefore, result in lower running costs and solvent disposal.

The analytical HPLC-MS market is a $5 billion market today, according to Top Down Analytics, 2019 Outlook; Analytical Instruments Industry. 

Glen Mella, CEO, Axcend commented: "We have an award-winning, lightweight and powerful HPLC that is easy-to-use and cost-competitive, especially on an operational basis. Yet many scientists need the added benefit of an LC/MS system to produce greater analytical insights. We are confident that Microsaic will be an excellent partner for delivering compelling solutions to our customers."

Glenn Tracey, CEO, Microsaic added: "We are particularly excited by this partnership, which combines two highly differentiated compact products into a very powerful LC/MS system. In addition to the benefits for customers, this collaboration also leverages our shared resources of marketing, direct sales and distribution channels globally. As far as we are aware there is no other LC/MS combination today which provides such a powerful offering in such a small footprint."

 

Enquiries:

 

 

Microsaic Systems plc

Glenn Tracey, CEO

Bevan Metcalf, FD

+44 (0) 1483 751 577

 

N+1 Singer (Nominated Adviser & Broker)

Aubrey Powell / George Tzimas (Corporate Finance)

Tom Salvesen (Corporate Broking)

 

 

+44 (0)20 7496 3000

IFC Advisory Ltd (Financial PR)

Graham Herring

Florence Chandler

+44 (0)20 3934 6630

 

About Microsaic Systems

Microsaic Systems plc (AIM: MSYS) is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry ("MS") instruments that are designed to improve the efficiency of pharmaceutical R&D and manufacturing. The Company is working with a range of established global life science OEM partners, distributors and research organisations to co-develop and commercialise new solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines. MS is a powerful method of analysis to enable earlier decision making relating to product identification, purity and bioactivity, and is the analytical technique of choice for biochemists across many industry sectors.

 

Microsaic's core products, the 4500 MiD®, and MiD®ProteinID are robust and compact MS systems, retaining the functionality of larger conventional MS systems, easier to use by non-specialists, consuming less energy and having lower running costs. For more information, please go to www.microsaic.com.

 

About Axcend

Based in Provo, Utah, Axcend is a provider of innovative, compact nano-flow, high-performance liquid chromatography (HPLC) systems. These systems allow scientists to Take the Lab to the Sample™ and deliver dramatic improvements in portability, ease-of-operation, and rapid and convenient deployment, as well as coupling to other analytical systems (such as mass spectrometers).

 

For more information please go to www.axcendcorp.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRFELLLBLLBBBV
Date   Source Headline
15th Mar 20227:00 amRNSBoard Appointment and Strategic Update
8th Mar 20224:35 pmRNSPrice Monitoring Extension
7th Mar 20222:05 pmRNSSecond Price Monitoring Extn
7th Mar 20222:00 pmRNSPrice Monitoring Extension
21st Feb 20221:31 pmRNSHolding(s) in Company
17th Feb 20222:45 pmRNSHolding(s) in Company
16th Feb 202211:06 amRNSSecond Price Monitoring Extn
16th Feb 202211:00 amRNSPrice Monitoring Extension
14th Feb 20227:00 amRNSDirector Dealing, Issue of Equity and TVR
28th Jan 20227:00 amRNSResignation of Chief Executive Officer
12th Jan 20224:43 pmRNSHolding(s) in Company
10th Jan 20223:30 pmRNSInvestor Presentation
10th Jan 20227:00 amRNSTrading Update
7th Jan 20222:06 pmRNSSecond Price Monitoring Extn
7th Jan 20222:00 pmRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSFurther order from DeepVerge
12th Nov 20217:00 amRNSNew compact screening platform
5th Nov 202110:12 amRNSHolding(s) in Company
27th Oct 20217:00 amRNSLaunch of technology for scaling drug manufacture
22nd Oct 20217:00 amRNSBoard Change
21st Oct 20217:00 amRNSUpdate on DeepVerge Collaboration
28th Sep 20214:30 pmRNSHolding(s) in Company
27th Sep 20217:00 amRNSInterim Results
24th Sep 20217:00 amRNSSigning of agreement to support China operations
22nd Sep 202111:06 amRNSNotice of Results and Investor Presentation
27th Aug 20214:40 pmRNSSecond Price Monitoring Extn
27th Aug 20214:35 pmRNSPrice Monitoring Extension
23rd Aug 20217:00 amRNSDeepVerge Collaboration for Water & Soil Analysis
9th Aug 20217:00 amRNSHeads of Terms signed with manufacturer in China
6th Jul 202111:55 amRNSInvestor Presentation
6th Jul 20217:00 amRNSTrading update for H1 2021
5th Jul 20219:50 amRNSHolding(s) in Company
2nd Jul 20217:00 amRNSDevelopment of real-time monitoring solution
17th Jun 202110:54 amRNSResult of Annual General Meeting
4th Jun 20217:00 amRNSPre-Annual General Meeting Q&A
25th May 20217:00 amRNSDevelopment of PFAS detection platform
20th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
4th May 20219:00 amRNSPrice Monitoring Extension
4th May 20217:01 amRNSHeads of Terms signed for Chinese market
4th May 20217:00 amRNSFinal Results
28th Apr 20217:00 amRNSNotice of Results and Investor Presentation
31st Mar 20214:41 pmRNSSecond Price Monitoring Extn
31st Mar 20214:36 pmRNSPrice Monitoring Extension
24th Mar 20217:00 amRNSFramework Services Agreement Update
9th Mar 20212:52 pmRNSHolding(s) in Company
9th Mar 20212:06 pmRNSSecond Price Monitoring Extn
9th Mar 20212:01 pmRNSPrice Monitoring Extension
4th Mar 20217:00 amRNSHolding(s) in Company
3rd Mar 20214:41 pmRNSSecond Price Monitoring Extn
3rd Mar 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.